SoftBank Nears $6.5B Deal for Ampere; Bain Capital Acquires Mitsubishi Chemical Group's Tanabe Pharma for 510 Billion Yen

SoftBank Group Corp. is reportedly nearing a $6.5 billion acquisition of Ampere, a chipmaker founded by Renee James. The deal is part of SoftBank's strategy to enhance its semiconductor portfolio. Concurrently, Bain Capital has agreed to acquire Mitsubishi Chemical Group Corp.'s pharmaceutical unit, Mitsubishi Tanabe Pharma, for approximately 510 billion yen, or $3.4 billion. This acquisition is expected to bolster Bain's investment in Japan's pharmaceutical sector amid anticipated regulatory changes that could streamline drug development processes. Both transactions reflect ongoing trends in private equity and technology investments in Japan.